Lee S Cohen
Examiner (ID: 29, Phone: (571)272-4763 , Office: P/3739 )
Most Active Art Unit | 3739 |
Art Unit(s) | 0, 3739, 3794, 3736, 3305, 3311 |
Total Applications | 3720 |
Issued Applications | 3004 |
Pending Applications | 173 |
Abandoned Applications | 543 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 7674635
[patent_doc_number] => 20040127483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-01
[patent_title] => 'Pyrazolopyrimidines as CRF receptor antagonists'
[patent_app_type] => new
[patent_app_number] => 10/665740
[patent_app_country] => US
[patent_app_date] => 2003-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12730
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20040127483.pdf
[firstpage_image] =>[orig_patent_app_number] => 10665740
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/665740 | Pyrazolopyrimidines as CRF receptor antagonists | Sep 18, 2003 | Issued |
Array
(
[id] => 7411763
[patent_doc_number] => 20040106631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-03
[patent_title] => 'Spirocondensed quinazolinones and their use as phosphodiesterase inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/667111
[patent_app_country] => US
[patent_app_date] => 2003-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8763
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20040106631.pdf
[firstpage_image] =>[orig_patent_app_number] => 10667111
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/667111 | Spirocondensed quinazolinones and their use as phosphodiesterase inhibitors | Sep 16, 2003 | Issued |
Array
(
[id] => 7169361
[patent_doc_number] => 20040077630
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-22
[patent_title] => 'Allosteric adenosine receptor modulators'
[patent_app_type] => new
[patent_app_number] => 10/663243
[patent_app_country] => US
[patent_app_date] => 2003-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17148
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20040077630.pdf
[firstpage_image] =>[orig_patent_app_number] => 10663243
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/663243 | Allosteric adenosine receptor modulators | Sep 14, 2003 | Abandoned |
Array
(
[id] => 5748444
[patent_doc_number] => 20060111376
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-25
[patent_title] => '2,4-Diamino quinazoline and pyridopyrimidine ester derivatives as dihydrofolate reductase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/525906
[patent_app_country] => US
[patent_app_date] => 2003-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7014
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20060111376.pdf
[firstpage_image] =>[orig_patent_app_number] => 10525906
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/525906 | 2,4-Diamino quinazoline and pyridopyrimidine ester derivatives as dihydrofolate reductase inhibitors | Aug 26, 2003 | Abandoned |
Array
(
[id] => 7367837
[patent_doc_number] => 20040092515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-13
[patent_title] => 'Diaminoquinazoline esters for use as dihydrofolate reductase inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/468151
[patent_app_country] => US
[patent_app_date] => 2003-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10479
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20040092515.pdf
[firstpage_image] =>[orig_patent_app_number] => 10468151
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/468151 | Diaminoquinazoline esters for use as dihydrofolate reductase inhibitors | Aug 26, 2003 | Abandoned |
Array
(
[id] => 7474012
[patent_doc_number] => 20040121998
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-24
[patent_title] => 'CRF antagonistic quino- and quinazolines'
[patent_app_type] => new
[patent_app_number] => 10/648843
[patent_app_country] => US
[patent_app_date] => 2003-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7946
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0121/20040121998.pdf
[firstpage_image] =>[orig_patent_app_number] => 10648843
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/648843 | CRF antagonistic quino- and quinazolines | Aug 25, 2003 | Abandoned |
Array
(
[id] => 7265036
[patent_doc_number] => 20040242572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture'
[patent_app_type] => new
[patent_app_number] => 10/647156
[patent_app_country] => US
[patent_app_date] => 2003-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 73751
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20040242572.pdf
[firstpage_image] =>[orig_patent_app_number] => 10647156
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/647156 | New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture | Aug 21, 2003 | Abandoned |
Array
(
[id] => 7355360
[patent_doc_number] => 20040048853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-11
[patent_title] => 'Compounds, compositions, and methods'
[patent_app_type] => new
[patent_app_number] => 10/644244
[patent_app_country] => US
[patent_app_date] => 2003-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17467
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20040048853.pdf
[firstpage_image] =>[orig_patent_app_number] => 10644244
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/644244 | Compounds, compositions, and methods | Aug 19, 2003 | Abandoned |
Array
(
[id] => 7404560
[patent_doc_number] => 20040023996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-05
[patent_title] => 'Methods and compositions utilizing quinazolinones'
[patent_app_type] => new
[patent_app_number] => 10/312323
[patent_app_country] => US
[patent_app_date] => 2003-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 90
[patent_figures_cnt] => 90
[patent_no_of_words] => 16549
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0023/20040023996.pdf
[firstpage_image] =>[orig_patent_app_number] => 10312323
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/312323 | Methods and compositions utilizing quinazolinones | Aug 14, 2003 | Abandoned |
Array
(
[id] => 7314521
[patent_doc_number] => 20040034032
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-19
[patent_title] => 'Quinoline and quinazoline compounds useful in therapy'
[patent_app_type] => new
[patent_app_number] => 10/640314
[patent_app_country] => US
[patent_app_date] => 2003-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12277
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20040034032.pdf
[firstpage_image] =>[orig_patent_app_number] => 10640314
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/640314 | Quinoline and quinazoline compounds useful in therapy | Aug 12, 2003 | Abandoned |
Array
(
[id] => 7136310
[patent_doc_number] => 20040044012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-04
[patent_title] => 'Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation'
[patent_app_type] => new
[patent_app_number] => 10/638848
[patent_app_country] => US
[patent_app_date] => 2003-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30386
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20040044012.pdf
[firstpage_image] =>[orig_patent_app_number] => 10638848
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/638848 | Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation | Aug 10, 2003 | Abandoned |
Array
(
[id] => 7150854
[patent_doc_number] => 20040171543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-02
[patent_title] => 'Matrix metalloproteinase inhibitors and methods for identification of lead compounds'
[patent_app_type] => new
[patent_app_number] => 10/637942
[patent_app_country] => US
[patent_app_date] => 2003-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 19482
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20040171543.pdf
[firstpage_image] =>[orig_patent_app_number] => 10637942
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/637942 | Matrix metalloproteinase inhibitors and methods for identification of lead compounds | Aug 6, 2003 | Abandoned |
Array
(
[id] => 7281357
[patent_doc_number] => 20040063734
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-01
[patent_title] => '4,4-Disubstituted-3,4-dihydro-2 (1H)-quinazoliniones useful as HIV reverse transcriptase inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/632192
[patent_app_country] => US
[patent_app_date] => 2003-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10815
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20040063734.pdf
[firstpage_image] =>[orig_patent_app_number] => 10632192
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/632192 | 4,4-Disubstituted-3,4-dihydro-2 (1H)-quinazoliniones useful as HIV reverse transcriptase inhibitors | Jul 30, 2003 | Abandoned |
Array
(
[id] => 7677130
[patent_doc_number] => 20040152696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-05
[patent_title] => '2-substituted bicyclic benzoheterocyclic compounds and their use as sodium channel blockers'
[patent_app_type] => new
[patent_app_number] => 10/628487
[patent_app_country] => US
[patent_app_date] => 2003-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11720
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20040152696.pdf
[firstpage_image] =>[orig_patent_app_number] => 10628487
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/628487 | 2-substituted bicyclic benzoheterocyclic compounds and their use as sodium channel blockers | Jul 28, 2003 | Abandoned |
Array
(
[id] => 7310619
[patent_doc_number] => 20040142949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-22
[patent_title] => 'Compounds, compositions, and methods'
[patent_app_type] => new
[patent_app_number] => 10/626012
[patent_app_country] => US
[patent_app_date] => 2003-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22303
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20040142949.pdf
[firstpage_image] =>[orig_patent_app_number] => 10626012
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/626012 | Compounds, compositions, and methods | Jul 22, 2003 | Issued |
Array
(
[id] => 606497
[patent_doc_number] => 07153862
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-12-26
[patent_title] => 'αv integrin receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 10/618414
[patent_app_country] => US
[patent_app_date] => 2003-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39369
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 549
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/153/07153862.pdf
[firstpage_image] =>[orig_patent_app_number] => 10618414
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/618414 | αv integrin receptor antagonists | Jul 9, 2003 | Issued |
Array
(
[id] => 699351
[patent_doc_number] => 07067519
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-06-27
[patent_title] => '7,8,9,10-tetrahydro-6H-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2H-pyrrolo[2,1-b]-quinazolinone derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/489350
[patent_app_country] => US
[patent_app_date] => 2003-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13995
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/067/07067519.pdf
[firstpage_image] =>[orig_patent_app_number] => 10489350
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/489350 | 7,8,9,10-tetrahydro-6H-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2H-pyrrolo[2,1-b]-quinazolinone derivatives | Jul 7, 2003 | Issued |
Array
(
[id] => 7046202
[patent_doc_number] => 20050250797
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => 'Quinzoline derivatives for use in the treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 10/520266
[patent_app_country] => US
[patent_app_date] => 2003-07-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 66631
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0250/20050250797.pdf
[firstpage_image] =>[orig_patent_app_number] => 10520266
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/520266 | Quinzoline derivatives for use in the treatment of cancer | Jul 3, 2003 | Issued |
Array
(
[id] => 7387334
[patent_doc_number] => 20040029901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-12
[patent_title] => 'Quinazoline derivatives'
[patent_app_type] => new
[patent_app_number] => 10/613782
[patent_app_country] => US
[patent_app_date] => 2003-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10627
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20040029901.pdf
[firstpage_image] =>[orig_patent_app_number] => 10613782
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/613782 | Quinazoline derivatives | Jul 2, 2003 | Issued |
Array
(
[id] => 5711042
[patent_doc_number] => 20060052387
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Organic compounds'
[patent_app_type] => utility
[patent_app_number] => 10/519654
[patent_app_country] => US
[patent_app_date] => 2003-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3250
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20060052387.pdf
[firstpage_image] =>[orig_patent_app_number] => 10519654
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/519654 | Organic compounds | Jun 25, 2003 | Abandoned |